Search results for "From Annals of Internal Medicine"
Annals On Call: First-line drug therapy for type 2 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode covered a study of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists as first-line therapy.
https://diabetes.acponline.org/archives/2023/03/10/6.htm
10 Mar 2023
Case report involving diabetes published
The report details how unrecognized type 1 diabetes predisposed a 24-year-old patient with a recent type 2 diabetes diagnosis to develop sodium-glucose cotransporter-2 inhibitor therapy-induced euglycemic diabetic ketoacidosis.
https://diabetes.acponline.org/archives/2023/01/13/7.htm
13 Jan 2023
Low-carb diet improved diabetes control, but effects didn't last
Patients with type 2 diabetes randomized to a low-carb, high-fat diet for six months showed more improvement in HbA1c level than those assigned to a low-fat, high-carb diet, a Danish trial found.
https://diabetes.acponline.org/archives/2023/01/13/6.htm
13 Jan 2023
California's insulin plan, clinical decision support in lower-income countries
Recent articles from Annals of Internal Medicine discussed California's plan to produce insulin and a diabetes clinical decision support system that may be helpful in primary care in low- to middle-income countries.
https://diabetes.acponline.org/archives/2022/12/09/8.htm
9 Dec 2022
Case reports involving diabetes published
New case reports describe osteomyelitis pubis and nonislet cell tumor hypoglycemia.
https://diabetes.acponline.org/archives/2022/11/11/8.htm
11 Nov 2022
More than 15% of U.S. insulin users had to ration in the past year, study finds
Rationing was more common among younger patients, Black patients, and uninsured patients, according to an analysis of the 2021 National Health Interview Survey.
https://diabetes.acponline.org/archives/2022/11/11/7.htm
11 Nov 2022
In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
An analysis of recent manufacturer-sponsored studies of finerenone show it to be a potentially important new treatment for patients with type 2 diabetes and albuminuric chronic kidney disease (CKD), although it poses risk for serious hyperkalemia, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2022/05/13/6.htm
13 May 2022
Recent articles address federal diabetes programs, type 1 diabetes care
The National Clinical Care Commission made 39 recommendations for improving federal diabetes programs, and the latest In the Clinic article offered advice on diagnosing and treating type 1 diabetes.
https://diabetes.acponline.org/archives/2022/03/11/6.htm
11 Mar 2022
Bariatric surgeries reduced hepatic steatosis in type 2 diabetes at one year
Patients who were randomized to either sleeve gastrectomy or Roux-en-Y gastric bypass showed similar improvements in hepatic steatosis and fibrosis, a randomized trial in Norway found.
https://diabetes.acponline.org/archives/2021/12/10/6.htm
10 Dec 2021
SGLT-2s reduced risk for heart failure hospitalization compared to GLP-1s
The retrospective, nonrandomized comparison also found that risk for myocardial infarction or stroke differed by whether type 2 diabetes patients had cardiovascular disease at the time they started a sodium-glucose cotransporter-2 (SGLT-2) inhibitor or glucagon-like peptide-1 (GLP-1) receptor agonist.
https://diabetes.acponline.org/archives/2021/10/08/6.htm
8 Oct 2021